_1777370220974_847775619.png&w=48&q=75){kind=small}
Revolution Medicines wins FDA approval for pancreatic cancer drug
The U.S. Food and Drug Administration approved Revolution Medicines’ targeted drug for adults with metastatic pancreatic cancer who have received previous treatment or cannot tolerate combination chemotherapy.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading